合成阴子载体消灭耐药黄金葡萄球菌,持久菌和生物膜
Pak-Ming Fong1, Victor Yat-Man Tang2, Lu Xu3
1Morningside Laboratory for Chemical Biology, Department of Chemistry, The University of Hong Kong, Pokfulam, Hong Kong 999077, P. R. China.
JACS Au
|March 28, 2025
概括
新的合成阴离子载体有效地对抗抗甲素耐药的金黄色葡萄球菌 (MRSA) 感染. 这些化合物向细菌离子平衡,消除持久细胞和生物膜,对宿主细胞的毒性最小.
科学领域:
- 药用化学 医学化学
- 发现抗微生物药物 发现抗微生物药物
- 分子生物学分子生物学
背景情况:
- 甲素耐药黄金葡萄球菌 (MRSA) 构成了全球严重的健康威胁.
- 由于耐抗生素的持久细胞和生物膜,MRSA感染具有挑战性.
- 现有的抗生素往往对这些耐药形式无效.
研究的目的:
- 设计和合成基于氨基酸的新型二,作为潜在的抗MRSA药物.
- 研究这些化合物对浮游生物MRSA,持久细胞和生物膜的疗效.
- 阐明作用机制,并评估体内疗效和宿主毒性.
主要方法:
- 基于氨基氧酸的二的合成.
- 在体外对MRSA,持久细胞和生物膜的抗菌活性的评估.
- 对哺乳动物细胞的选择性评估.
- 在小鼠感染模型 (皮肤和血液) 的体内疗效研究.
- 作用模式研究,包括离子稳态中断和自解诱导.
主要成果:
- 合成阴离子载体显示出对MRSA的强烈抗菌活性.
- 化合物有效地根除了持久性细胞,并减少了已建立的生物膜.
- 观察到细菌细胞对哺乳动物细胞的高选择性.
- 在体内研究表明,在没有宿主毒性的小鼠模型中,有效降低MRSA负担.
- 机制涉及破坏细菌离子稳态,导致细胞质酸性化,高极化,流入,加速自溶.
结论:
- 基于氨基氧酸的二是一种有前途的新型合成阴离子载体.
- 这些化合物显示出治疗具有挑战性的MRSA感染的巨大潜力,包括那些涉及持久性和生物膜的感染.
- 它们有利的安全性和新的机制为抗生素耐药性提供了可行的策略.
相关概念视频
Drug Elimination by Renal Route: Tubular Secretion
Once the process of glomerular filtration is completed, blood carrying unfiltered drug molecules traverses through efferent arterioles and makes its way into the peritubular capillaries in the proximal tubule. A variety of carriers play a pivotal role in actively secreting drugs from these peritubular capillaries into the tubular fluid. The organic anion transporter transfers acidic drugs, against an electrochemical gradient, from the peritubular capillaries into the renal tubule cells and...
Carrier-Mediated Transport
Carrier-mediated transport is a pivotal process in drug absorption, particularly for lipid-insoluble drugs, and encompasses facilitated diffusion and active transport. Facilitated diffusion allows drugs to move along their concentration gradient without energy expenditure, while active transport utilizes ATP to drive drug movement against this gradient.
Active transport involves two types of membrane-spanning transporters: uptake and efflux. Uptake transporters are expressed in the small...
Active transport involves two types of membrane-spanning transporters: uptake and efflux. Uptake transporters are expressed in the small...
Development of Antibiotic Resistance
Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
Staphylococcal Skin Infections
Staphylococcus aureus is a Gram-positive coccus that resides harmlessly on the skin and mucous membranes of healthy individuals. When the skin barrier is breached, it can shift from a commensal to an opportunistic pathogen. This transition is facilitated by surface adhesins, such as clumping factor B and S. aureus surface protein G (SasG), which bind to structural proteins, including loricrin and cytokeratin, in the damaged epidermis. Protein A, another key factor, binds the Fc region of...
Mechanism of Antibiotic Resistance in MRSA
Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Clinical Significance of Antibiotic Resistance
Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...


